Teclistamab is the first bispecific antibody worldwide to be approved for patients with relapsed and refractory multiple myeloma
With the help of cryo-electron microscopy, biochemists and structural biologists from Goethe University Frankfurt, in collaboration the University […]
Updated Date: Wed, 17 Aug 2022 00:00:00 EDT
Updated Date: Wed, 17 Aug 2022 00:00:00 EDT
Updated Date: Wed, 17 Aug 2022 00:00:00 EDT
Updated Date: Wed, 17 Aug 2022 00:00:00 EDT
Updated Date: Wed, 17 Aug 2022 00:00:00 EDT
In a survey study of more than 3,000 adults, researchers compared psychedelic experiences with near-death experiences that were […]
A team led by Dr. Maximilian Kückelhaus and Prof. Tobias Hirsch from the Centre for Musculoskeletal Medicine at […]
